2012, ISBN: 9782817803364
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and … Más…
| Orellfuessli.ch Nr. 34928972. Gastos de envío:, Sofort per Download lieferbar, zzgl. Versandkosten, Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage. (EUR 16.66) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), Auflage, [PU: Springer-Verlag], [ED: 1], Springer-Verlag, 2012
| lehmanns.de Gastos de envío:Download sofort lieferbar. (EUR 29.95) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, [ED: 1], Auflage, eBook Download (PDF), eBooks, [PU: Springer-Verlag]
| lehmanns.de Gastos de envío:Download sofort lieferbar, , Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), 2012, [PU: Springer Paris], Springer Paris, 2012
| lehmanns.de Gastos de envío:Download sofort lieferbar. (EUR 0.00) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, 2012, eBook Download (PDF), eBooks, [PU: Springer Paris]
| lehmanns.de Gastos de envío:Download sofort lieferbar, , Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
2012, ISBN: 9782817803364
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and … Más…
2012
ISBN: 9782817803364
A New Generation of Biologics, [ED: 1], Auflage, eBook Download (PDF), eBooks, [PU: Springer-Verlag]
2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), 2012, [PU: Springer Paris], Springer Paris, 2012
2012, ISBN: 9782817803364
A New Generation of Biologics, 2012, eBook Download (PDF), eBooks, [PU: Springer Paris]
Datos bibliográficos del mejor libro coincidente
| Autor: | |
| Título: | |
| ISBN: |
Detalles del libro - Biosimilars
EAN (ISBN-13): 9782817803364
ISBN (ISBN-10): 2817803361
Año de publicación: 2012
Editorial: Springer-Verlag
87 Páginas
Idioma: eng/Englisch
Libro en la base de datos desde 2012-09-27T17:56:33+02:00 (Madrid)
Página de detalles modificada por última vez el 2023-03-01T02:27:40+01:00 (Madrid)
ISBN/EAN: 9782817803364
ISBN - escritura alterna:
2-8178-0336-1, 978-2-8178-0336-4
Mode alterno de escritura y términos de búsqueda relacionados:
Autor del libro: hugues, jean louis lou
Datos del la editorial
Autor: Jean-Louis Prugnaud; Jean-Hugues Trouvin
Título: Biosimilars - A New Generation of Biologics
Editorial: Springer; Springer Paris
90 Páginas
Año de publicación: 2012-11-27
Paris; FR
Impreso en
Idioma: Inglés
117,69 € (DE)
142,00 CHF (CH)
Available
XVIII, 90 p.
EA; E107; eBook; Nonbooks, PBS / Medizin/Klinische Fächer; Onkologie; Verstehen; Biomedicine; Biosimilars; Cost; Immunogenicity; Interchangeability; C; Oncology; Nephrology; Pharmacy; Pharmaceutical Sciences/Technology; Immunology; Oncology; Nephrology; Pharmacy; Pharmaceutics; Immunology; Medicine; Nierenheilkunde, Nephrologie; Pharmazie, Apotheke; Medizinische Chemie, Pharmazeutische Chemie; Immunologie; BB
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context.Más, otros libros, que pueden ser muy parecidos a este:
Último libro similar:
9782817805146 Biosimilars (Jean-Louis Prugnaud; Jean-Hugues Trouvin)
< para archivar...